Biotechnology Today
more-
Molecular Partners rethinks tetra-specific dosing after seeing ‘suboptimal exposure’ in cancer trial
Molecular Partners has identified “suboptimal exposure” to its tetra-specific T-cell engager as the potential cause…
Duality plans Hong Kong IPO to fund trials of BioNTech-partnered ADCs and beyond
Vaderis scores win against rare blood vessel disorder as trial shows its drug reduces nosebleeds
Siemens Healthineers to acquire Novartis’ European radiodiagnostic manufacturing network
Galapagos investor signals intent to influence company’s control, argues the biotech is ‘deeply undervalued’
Markets
more-
Weekly Market Review – November 30, 2024
Stock Markets All major indexes are up for the week. The 30-stock Dow Jones Industrial…
Bio Space
more
Navigator charts course for newly acquired autoimmune pipeline with $100M series A
Navigator Medicines has equipped itself with $100 million in series…
Federal health agency awards University of Illinois over $50M to improve tumor treatment, R&D
The U.S. Department of Health and Human Services is sowing…
Getinge enters transplant market, buying organ transport specialist Paragonix for $477M
Organ preservation and transport company Paragonix Technologies has agreed to…
Global News
more
SpaceX Starlink wins permit to send internet to customers like you
SpaceX has been busy building its Starlink satellite constellation. To…
Facebook video calls soar 1000% during Italy’s lockdown
Facebook has seen usage across its platforms surge in countries…
WeWork board’s special committee is demanding that SoftBank follow through with investment
Five months after SoftBank agreed to a massive bailout of…
Molecular Partners rethinks tetra-specific dosing after seeing ‘suboptimal exposure’ in cancer trial
Duality plans Hong Kong IPO to fund trials of BioNTech-partnered ADCs and beyond
Vaderis scores win against rare blood vessel disorder as trial shows its drug reduces nosebleeds
Siemens Healthineers to acquire Novartis’ European radiodiagnostic manufacturing network
Navigator charts course for newly acquired autoimmune pipeline with $100M series A
Federal health agency awards University of Illinois over $50M to improve tumor treatment, R&D
Getinge enters transplant market, buying organ transport specialist Paragonix for $477M
Following growth spurt, Arctoris builds out new executive team
Weekly Market Review – November 30, 2024
Galapagos investor signals intent to influence company’s control, argues the biotech is ‘deeply undervalued’